PQ 21
21. Deputy Clare Daly asked the Minister for Health if he will provide the detail of the information held by his Department after November 2009 regarding the safety profile of the Pandemrix vaccine compared to other vaccines for swine flu; and if his Department was briefed by the Irish Medicines Board as to the heightened risk of serious adverse drug reactions associated with the drug. [20206/17]
Introduced
3 May 2017
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
3 May 2017
Summary
21. Deputy Clare Daly asked the Minister for Health if he will provide the detail of the information held by his Department after November 2009 regarding the safety profile of the Pandemrix vaccine compared to other vaccines for swine flu; and if his Department was briefed by the Irish Medicines Board as to the heightened risk of serious adverse drug reactions associated with the drug. [20206/17]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Vaccination Programme
Vaccination Programme
xml · EN · 3 May 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2017-05-03/21/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2017-05-03/pq_21